To contents
Theoretical Physics
01-3-1135-2019/2023
01-3-1136-2019/2023
01-3-1137-2019/2023
01-3-1138-2019/2023
01-3-1117-2014/2023
Elementary Particle Physics
02-2-1123-2015/2022
02-0-1081-2009/2024
02-2-1144-2021/2023
02-2-1099-2010/2023
02-0-1108-2011/2021
02-2-1125-2015/2023
02-1-1106-2011/2022
02-1-1096-2010/2022
02-0-1083-2009/2022
02-0-1085-2009/2022
02-1-1086-2009/2023
02-0-1065-2007/2023
02-0-1127-2016/2023
02-1-1097-2010/2021
02-1-1087-2009/2023
02-0-1066-2007/2023
02-1-1088-2009/2022
02-1-1107-2011/2021
Nuclear Physics
03-0-1129-2017/2021
03-5-1130-2017/2021
03-2-1100-2010/2021
03-4-1128-2017/2022
Condensed Matter Physics
04-4-1142-2021/2025
04-4-1105-2011/2022
04-4-1143-2021/2025
04-4-1133-2018/2023
04-4-1140-2020/2022
04-4-1141-2020/2022
04-5-1131-2017/2021
04-9-1077-2009/2023
04-9-1112-2013/2022
04-2-1132-2017/2022
    04-2-1132 - RUS
04-2-1126-2015/2023
Networking, Computing
05-6-1118-2014/2023
05-6-1119-2014/2023
Educational Programme
06-0-1139-2019/2023

04-2-1132-2017/2022

 

Priority:

1

 

 

Status:

In-progress


Biomedical and Radiation-Genetic Studies Using Different Types
of Ionizing Radiation

Leader

G.V. Mitsyn
S.L. Yakovenko

Deputy:

S.V. Shvidky


Participating countries and international organizations:
Belgium, China, Czech Republic, India, Moldova, Poland, Romania, Russia, South Africa, USA.

Issues addressed and main goals of research:
Mdico-biological and clinical research for the proton radiotherapy of cancer patients. Formation of an experimental data base in the field of radiation mutagenesis in the animal germ cells.

Expected results in the current year:

  • Evaluation of the effectiveness of the conducted radiation treatment of different neoplasms.

  • Work to increase the functional capability of the developed 3D treatment planning software.

  • Design and construction of the prototype equipment for the dynamic conformal irradiation of deep-seated tumours with the proton beam.

  • Development and improvement of detectors and tools for the clinical dosimetry of the medical hadron beams.

  • Continuation of research to determine forms of fibroblast cell death depending on the dose of ionizing radiation.

  • Study of mechanisms of functional and neurochemical disorders in the central nervous system under the action of radiation with different linear energy transfer.

  • Mastering of new methodes for evaluation of the effectiveness of the cytotoxic action of nanoparticles on tumour cells.

  • Continuation of the molecular analysis of gamma- and neutron-induced intragenic structural changes in germline cells.

  • Continuation of the sequence analysis of inherited DAN changes at the genome level of the offspring.

  • Continuation of the work on the analysis of the transcriptome in somatic cells differing in radiosensitivity.

  • Assessment of radioresistance of D.melanogaster strains and human cell line HEK293 expressing DSUP protein (gamma rays, protons, heavy ions)/

  • Transcriptome analysis of D.melanogaster strains and human cell line HEK293 expressing Dsup protein.

  • Study of distribution GEP-Dsup fusion protein on D.melanogater polytene chromosomes.

  • Develop a project of specialized isochronous cyclotron for proton therapy.

  • Measure the magnetic field of the MC1 bending magnet for the transport line of the AIC-144, Krakow, Poland.


List of projects:


 

Project

Leader

Priority
(period of realisation)

1.

Further development of methods,
technologies, schedule modes and
delivery of radiotherapy


G.V. Mitsyn
K.Sh. Voskanyan

1   (2017-2022)


2.

RADIOGENE: Molecular genetics of
radiation-induced changes at the gene,
genome and transcriptome level in
Drosophila melanogaster


I.D. Alexandrov

1   (2017-2022)

3.

Study of the radioprotective properties of the Damage supressor (Dsup) protein on a model organism D.melanogaster and human cell culture HEK293

E.V. Kravchenko

1   (2021-2022)



List of Activities:


 

Activity or Experiment

Leaders

Status

 

    Laboratory or other
    Division of JINR

Main researchers

1.

Further development of methods,
technologies, schedule modes and
delivery of radiotherapy


G.V. Mitsyn
K.Sh. Voskanyan

R&D



 

DLNP

A.V. Agapov, O.V. Belov, I.V. Alexandrova, K. Belokopytova, G.V. Donskaya, V.N. Gaevsky, Ye.I. Luchin, I.I. Klochkov, I. Khosenova, I.Ye. Miller, A.G. Molokanov, S.A. Pisareva, A.V. Rzyanina, K.N. Shipulin, S.V. Shvidky, M.A. Tseytlina


2.

RADIOGENE: Molecular genetics
of radiation-induced changes at the
gene, genome and transcriptome
level in Drosophila melanogaster


I.D. Alexandrov

R&D



 

DLNP

M.V. Alexandrova, K.P. Afanasyeva, N.E. Kharchenko, S.V. Korablinova, L.N. Korovina, N.V. Orlova, A.N. Rusakovich, O.P. Solodilova


3.

Study of the radioprotective properties of the Damage supressor (Dsup) protein on a model organism D.melanogaster and human cell culture HEK293

E.V. Kravchenko

R&D



 

DLNP

A.E. Ivanova, O.A. Kuldoshina, A.V.Rzyanina, A.S. Yakunenko, M.P. Zarubin


4.

Development of methods and programs for creating cyclotron-type accelerators. Development and upgrade of cyclotrons for medical application

G.A. Karamysheva

Realization


 

DLNP

K.S. Bunyatov, A.F. Chesnov, S.B. Fedorenko, R.V. Galkin, A.L. Gibinsky, S.V. Gursky, S.N. Dolya, G.G. Kazakova, O.V. Karamyshev, I.N. Kiyan, O.E. Lepkina, O.V. Lomakina, I.V. Lyapin, V.A. Malinin, D.S. Petrov, D.V. Popov, G.D. Shirkov, S.G. Shirkov, V.L. Smirnov, A.S. Vorozhtsov, S.B. Vorozhtsov 


 

LIT

I.V. Amirhanov, T.V. Karamysheva 

 

Collaboration


Country or International Organization

City

Institute or laboratory

Belgium

Louvain-la-Neuve

IBA

China

Hefei

IPP CAS

Czech Republic

Prague

ADVACAM

 

 

PTC

 

Rez

UJV

Moldova

Chisinau

MSU

Poland

Krakow

INP PAS

 

Otwock (Swierk)

NCBJ

 

Poznan

GPCC

Romania

Bucharest

IFIN-HH

Russia

Dubna

RDH-9

 

Moscow

DMS RAS

 

 

FMBC

 

 

IBMP RAS

 

 

VIGG RAS

 

Rostov-on-Don

SFedU

South Africa

Somerset West

iThemba LABS

USA

Lansing, MI

IONETIX